Kelvin Gastelum sanctioned 9 months for second USADA anti-doping violation
The United States Anti-Doping Agency (USADA) announced today that UFC Kelvin Gastelum has accepted a 9-month suspension for a March 2017 anti-doping violation.
The violation stems from an in-competition test conducted a day after the UFC 244 event in November 2019.
According to USADA:
Gastelum, 28, tested positive for 11-nor-9-carboxy-tetrahydrocannabinol (Carboxy-THC) over the Decision Limit of 180 ng/mL, a urinary metabolite of Δ9-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, marijuana, and/or hashish as the result of a sample collected in-competition at UFC 244 New York, New York on November 3, 2019. Cannabis, marijuana, and hashish are Specified Substances in the class of Cannabinoids and prohibited in-competition under the UFC Prohibited List.
Under the UFC Anti-Doping Policy, Cannabinoids are considered Substances of Abuse. If an athlete can establish that the Substance of Abuse was not used to enhance his or her performance in a bout, the athlete is eligible for a reduction to his or her period of ineligibility upon the full and satisfactory completion of an approved rehabilitation program. Gastelum also tested positive for Carboxy-THC in 2017 and accepted the resulting sanction.
Gastelum’s nine-month period of ineligibility began on November 3, 2019, the date his positive sample was collected. Based on Gastelum’s successful completion of a drug treatment program, his period of ineligibility was reduced by five months.
In addition, Gastelum’s positive test falls under the jurisdiction of the New York State Athletic Commission, which is handling the case in accordance with its rules.
Gastelum’s first violation was in May 2017 at UFC Fight Night 106, which produced a 90-day suspension. His last bout was a split-decision loss to Darren Till at UFC 244 in November 2019.